The FDA approved marketing for twenty Zyn nicotine pouch products from Philip Morris International. These pouches come in various flavors like cinnamon, citrus, coffee, and mint. The FDA determined the benefits of switching to Zyn from cigarettes or smokeless tobacco outweigh the risks. The decision is based on evidence showing potential public health advantages. This approval gives Philip Morris a significant competitive edge in the oral nicotine market. The company holds a substantial market share of approximately 34.5%. The approval was announced in the final days of the Biden-Harris administration. The FDA also recently proposed reducing nicotine levels in cigarettes. The Zyn approval is considered a key development in the tobacco industry. This decision highlights a shift in regulatory approach towards potentially less harmful nicotine alternatives.
zerohedge.com
zerohedge.com
Create attached notes ...
